1 |
Akman RY, Koseoglu H, Oguzulgen AI, et al (2014). Prostate Biopsy in the Elderly: Histologic Findings and Treatment Necessity. Asian Pac J Cancer Prev, 15, 8937-9.
DOI
|
2 |
Albasri A, El-Siddig A, Hussainy A, et al (2014). Histopathologic characterization of prostate diseases in Madinah, Saudi Arabia. Asian Pac J Cancer Prev, 15, 4175-9.
DOI
|
3 |
Anderson-Jackson L, McGrowder DA, Alexander-Lindo R (2012). Prostate specific antigen and gleason score in men with prostate cancer at a private diagnostic radiology centre in Western Jamaica. Asian Pac J Cancer Prev, 13, 1453-6.
DOI
ScienceOn
|
4 |
Arafa MA, Rabah DM, Wahdan IH (2012). Awareness of general public towards cancer prostate and screening practice in arabic communities: a comparative multi-center study. Asian Pac J Cancer Prev, 13, 4321-6.
DOI
ScienceOn
|
5 |
Boyle P, Severi G, Giles GG (2003). The epidemiology of prostate cancer. Urol Clin North Am, 30, 209-17.
DOI
|
6 |
Burford DC, Kirby M, Austoker A (2010). Prostate cancer risk management programme information for primary care; PSA testing in asymptomatic men. evidence document. NHS Cancer Screening Programmes, 143-213.
|
7 |
Cihan YB, Arslan A, Ergul MA (2013). Subtypes of white blood cells in patients with prostate cancer or benign prostatic hyperplasia and healthy individuals. Asian Pac J Cancer Prev, 14, 4779-83.
DOI
ScienceOn
|
8 |
Dwivedi S, Goel A, Natu SM, et al (2011). Diagnostic and prognostic significance of prostate specific antigen and serum interleukin 18 and 10 in patients with locally advanced prostate cancer: a prospective study. Asian Pac J Cancer Prev, 12, 1843-8.
|
9 |
Felgueiras J, Silva JV, Fardilha M (2014). Prostate cancer: the need for biomarkers and new therapeutic targets. J Zhejiang Univ Sci B, 15, 16-42.
DOI
|
10 |
Ferlay J, Parkin DM, Steliarova-Foucher E (2010). Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer, 46, 765-81.
DOI
ScienceOn
|
11 |
Grivas N, Hastazeris K, Kafarakis V, et al (2012). Prostate cancer epidemiology in a rural area of north Western Greece. Asian Pac J Cancer Prev, 13, 999-1002.
DOI
ScienceOn
|
12 |
Heidenreich A, Bastian PJ, Bellmunt J, et al (2014). EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol, 65, 124-37.
DOI
ScienceOn
|
13 |
Kash DP, Lal M, Hashmi AH, et al (2014). Utility of digital rectal examination, serum prostate specific antigen, and transrectal ultrasound in the detection of prostate cancer: a developing country perspective. Asian Pac J Cancer Prev, 15, 3087-91.
DOI
|
14 |
Humphrey (2004). Gleason grading and prognostic factors in carcinoma of the prostate. Modern Pathology, 17, 292-306.
DOI
|
15 |
Ismail SI, Soubani M, Nimri JM, Al-Zeer AH (2013). Cancer incidence in Jordan from 1996 to 2009-A comprehensive study. Asian Pac J Cancer Prev, 14, 3527-34.
DOI
ScienceOn
|
16 |
Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300.
DOI
|
17 |
Madu CO, Lu Y (2010). Novel diagnostic biomarkers for prostate cancer. J Cancer, 6, 150-77.
|
18 |
Mosli HA, Abdel-Meguid TA, Al-Maghrabi JA, et al (2009). The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients. Saudi Med J, 30, 1439-43.
|
19 |
Nasseri K, Mills PK, Allan M (2007). Cancer incidence in the middle Eastern population of California, 1988-2004. Asian Pac J Cancer Prev, 8, 405-11.
|
20 |
Nelson WG, De Marzo AM, Isaacs WB (2003). Mechanisms of disease prostate cancer. N Engl J Med, 349, 366-81.
DOI
|
21 |
Rashid R, Mubarak M, Kazi J (2013). Frequency of adenocarcinoma in transrectal ultrasound-guided prostate needle biopsies in men with clinical suspicion of prostate cancer and raised serum prostate specific antigen. Middle East J Cancer, 4, 73-8.
|
22 |
Salim EI, Moore MA, Al-Lawati JA, et al (2009). Cancer epidemiology and control in the arab world-past, present and future. Asian Pac J Cancer Prev, 10, 3-16.
|
23 |
Yang B, Chen WH, Wen XF, et al (2013). Role of DNA repairrelated gene polymorphisms in susceptibility to risk of prostate cancer. Asian Pac J Cancer Prev, 14, 5839-42.
DOI
ScienceOn
|
24 |
Shamseddine A, Saleh A, Charafeddine M, et al (2014). Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018. Popul Health Metr, 12, 4.
DOI
|
25 |
Shariat SF, Roehrborn CG (2008). Using biopsy to detect prostate cancer. Rev Urol, 10, 262-80.
|
26 |
Verim L, Yildirim A, Basok EK, et al (2013). Impact of PSA and DRE on histologic findings at prostate biopsy in Turkish Men over 75 years of age. Asian Pac J Cancer Prev, 14, 6085-8.
DOI
ScienceOn
|
27 |
Zheng X-Y, Zhang P, Xie L-P, et al (2012). Prostate specific antigen velocity (PSAV) and PSAV per initial volume (PSAVD) for early detection of prostate cancer in Chinese men. Asian Pac J Cancer Prev, 13, 5529-33.
DOI
ScienceOn
|
28 |
Zorlu F, Zorlu R, Divrik RT, et al (2014). Prostate cancer incidence in Turkey: an epidemiological study. Asian Pac J Cancer Prev, 15, 9125-30.
DOI
|